Bioactive Components in Medicinal Orchids

Medicinal orchids have long attracted attention for their diverse secondary metabolites, ranging from simple phenolic acids to complex polyphenols and alkaloids. These bioactive components contribute to a wide spectrum of pharmacological effects, including antioxidant, anti-inflammatory, vasorelaxant and enzyme-inhibitory activities. Phenanthrenes and stilbenoids found in many terrestrial species underpin cardiovascular and metabolic benefits by modulating nitric oxide synthesis and calcium channels. Flavonoids and other phenolics confer free-radical scavenging capacity, supporting traditional uses in anti-ageing and hepatoprotective remedies. Network pharmacology analyses of tuber extracts have revealed multitarget interactions against enzymes implicated in diabetes, neurodegeneration and hyperpigmentation. Conservation of wild populations, coupled with micropropagation and sustainable harvesting, is critical to preserve genetic diversity and ensure reliable supply of these phytochemicals for clinical research and drug development.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Research from all publishers

Analyses of commercial Phalaenopsis hybrids have highlighted significant variation in phenolic profiles across leaves, roots and flowers. Eleven distinct phenolic acids—including protocatechuic, caffeic and ferulic acids—were quantified, with root extracts showing the highest antioxidant activity in both DPPH-scavenging and β-carotene bleaching assays. The localisation of ferulic, p-coumaric and sinapic acids in rhizomes suggests untapped value in industrial orchid waste for natural antioxidant production.

A network pharmacology study of Anacamptis pyramidalis tubers combined high-performance liquid chromatography with in silico target prediction to explore inhibitory effects on tyrosinase, α-amylase and α-glucosidase. Water and methanol extracts yielded gastrodin, caffeic acid derivatives and parishin, which demonstrated dose-dependent enzyme inhibition relevant to skin hyperpigmentation and type 2 diabetes. Docking simulations further supported interactions of oxo-dihydroxy octadecenoic acid with aldose reductase and PPAR-α, underscoring the tuber’s multitarget therapeutic potential.

Investigation of Eulophia macrobulbon tuber extract and its principal phenanthrene revealed potent vasorelaxant and acute hypotensive effects in rat mesenteric arteries. The active compound stimulated endothelium-dependent pathways via nitric oxide synthase activation and enhanced endothelium-derived hyperpolarisation, while also opening KCa channels and inhibiting extracellular and intracellular Ca2+ flux. These pleiotropic mechanisms highlight the promise of orchid-derived phenanthrenes as leads for novel cardiovascular agents.

Bioactive Components in Medicinal Orchids publication trend

The graph below shows the total number of articles in bioactive components in medicinal orchids across all publications each year (not limited to Nature Index journals).

Technical terms

Phenanthrene: A tricyclic aromatic hydrocarbon scaffold found in orchid tubers, often modified by hydroxyl and methoxy groups, with vasorelaxant and cytotoxic activities.

Phenolic compound: A class of plant secondary metabolites characterised by one or more hydroxylated aromatic rings, known for antioxidant and enzyme-inhibitory properties.

Flavonoid: A subgroup of phenolics featuring a C6–C3–C6 skeleton, widely distributed in orchid tissues and responsible for free-radical scavenging and anti-inflammatory effects.

α-Glucosidase: A digestive enzyme that cleaves carbohydrates to glucose; inhibition by orchid extracts can moderate postprandial glycaemia in diabetic management.

Network pharmacology: An integrative computational approach mapping phytochemical interactions across multiple biological targets to predict synergistic therapeutic effects.

References

1. Traditional, Therapeutic Uses and Phytochemistry of Terrestrial European Orchids and Implications for Conservation. Plants (2023).
2. Phenolic Compounds and Antioxidant Activity of Phalaenopsis Orchid Hybrids. Antioxidants (2016).
3. Phytochemical Analysis, Network Pharmacology and in Silico Investigations on Anacamptis pyramidalis Tuber Extracts. Molecules (2020).
4. Vasorelaxant and Hypotensive Effects of an Ethanolic Extract of Eulophia macrobulbon and Its Main Compound 1-(4′-Hydroxybenzyl)-4,8-Dimethoxyphenanthrene-2,7-Diol. Frontiers in Pharmacology (2018).